Roberto Rigatti

This inventor holds 67 USPTO granted patents and 8 published patent applications, plus 9 CIPO patents and 24 EPO patents, primarily in Nucleic Acid Sequencing (CPC class C12Q). Top assignees: Illumina Cambridge Limited, Illumina Corporation. Active years: 2010-2026.

USPTO Granted Patents = 67 (Patent Applications = 8)

% Patents Active = 83.6

CIPO Patents = 9 (Patent Applications = 1)

EPO Patents = 24 (Patent Applications = 26)

Average Co-Inventor Count = 3.4

ph-index = 15

Forward Citations = 1,120(Granted Patents)

Forward Citations (Not Self Cited) = 1,011(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Little Chesterford, GB (2012)
Walden, GB (2012 - 2015)
Saffron Walden, GB (2014 - 2019)
Nr. Saffron Walden, GB (2010 - 2020)
Arco, IT (2019 - 2021)
Essex, GB (2012 - 2023)
Nr Saffron Walden, GB (2014 - 2024)
Cambridge, GB (2019 - 2024)

Company Filing History:

58 out of 323

Illumina Cambridge Limited

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Sequencing

Sequencing Libraries

Monoclonal Clusters

Polynucleotide Amplification

Haplotype Determination

Density-Dependent GC Bias

Template Preparation

Sequencing Accuracy

Nucleic Acid Arrays

Polymerases

Amplification Methods

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12565716 - Methods and compositions for preparing sequencing libraries (2026-03-03),

2. 12385092 - Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid (2025-08-12),

3. 12319962 - Methods for sequencing polynucleotides (2025-06-03),

4. 12071711 - Method of preparing libraries of template polynucleotides (2024-08-27),

5. 12060554 - Method for selecting and amplifying polynucleotides (2024-08-13),

6. 11946096 - Methods for estimating cluster numbers (2024-04-02),

7. 11692223 - Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid (2023-07-04),

8. 11634707 - Methods and compositions for analyzing cellular components (2023-04-25),

9. 11605446 - Methods and systems for determining haplotypes and phasing of haplotypes (2023-03-14),

10. 11299765 - Methods and compositions for preparing sequencing libraries (2022-04-12),

11. 11279975 - Methods for sequencing polynucleotides (2022-03-22),

12. 11257568 - Methods and systems for determining haplotypes and phasing of haplotypes (2022-02-22),

13. 11142789 - Method of preparing libraries of template polynucleotides (2021-10-12),

14. 11142759 - Method for selecting and amplifying polynucleotides (2021-10-12),

15. 11060130 - Methods for estimating cluster numbers (2021-07-13),

Title: Innovator Spotlight: Roberto Rigatti, a Prolific Inventor in Molecular Biology

Introduction:

Roberto Rigatti, a talented inventor based near Saffron Walden, GB, has left a significant mark on the field of molecular biology with his remarkable innovations. With an impressive portfolio of 62 patents, Rigatti is a leading figure in the industry known for his groundbreaking contributions. Let's delve into his latest patents, career highlights, and collaborations that have shaped his innovative journey.

Latest Patents:

Among Roberto Rigatti's latest patents, two stand out for their significant impact on the field. The first patent revolves around "Methods for estimating cluster numbers," offering a novel approach to imaging template hybridization for estimating cluster numbers before solid phase amplification and sequencing. The second patent focuses on "Methods and arrays for producing and sequencing monoclonal clusters of nucleic acid," presenting innovative techniques for producing and sequencing monoclonal clusters, enhancing the efficiency of molecular biology processes.

Career Highlights:

During his illustrious career, Roberto Rigatti has made notable contributions while working at esteemed companies such as Illumina Cambridge Limited and Illumina Corporation. His expertise and dedication have led to pioneering advancements in the field of molecular biology, garnering recognition for his innovative prowess and technical acumen.

Collaborations:

Collaboration plays a key role in driving innovation, and Roberto Rigatti has had the privilege of working alongside talented individuals in his field. Some of his esteemed coworkers include Jonathan Mark Boutell and Geoffrey Paul Smith, who have collectively contributed to the success of various projects and initiatives, further solidifying Rigatti's reputation as a collaborative innovator.

Conclusion:

In conclusion, Roberto Rigatti's journey as an inventor in the realm of molecular biology serves as a testament to his passion for innovation and his unwavering commitment to pushing the boundaries of scientific discovery. With a rich portfolio of patents, impactful career milestones, and fruitful collaborations, Rigatti continues to inspire fellow inventors and researchers in the pursuit of cutting-edge advancements in the field.